Oramed Pharmaceuticals Inc. Share Price & Technical Analysis
ORMP · $3.99 (-8.90%)
Healthcare / Biotechnology
$3.99
-8.90%
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for CO…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
3% return in May, 23% avg return in past 3 year May month.
38% return in 2026, -4% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 17% | 3% | 0% | 15% | 3% | – | – | – | – | – | – | – | 38% |
| 25 | -12% | -5% | 0% | 5% | 0% | -4% | 0% | 0% | 24% | -8% | 22% | 0% | 22% |
| 24 | 30% | 10% | -12% | -23% | -4% | 18% | -4% | -4% | 0% | 0% | 0% | 0% | 11% |
| 23 | -84% | 5% | 0% | 5% | 74% | -10% | -6% | -3% | -21% | -31% | 22% | 5% | -45% |
| 22 | -38% | 13% | -16% | -42% | -12% | -2% | 91% | 0% | -23% | 9% | 17% | 41% | 39% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Uptrend · Neutral
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$175.94M
P/E ratio
2.9
52W high
$5.01
52W low
$1.98
Volume
1,55,576
Beta
1.26
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Oramed Pharmaceuticals Inc. share price today?
- Oramed Pharmaceuticals Inc. (ORMP) last traded around $3.99 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ORMP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ORMP. Download the app for real-time alerts.
- How can I analyze Oramed Pharmaceuticals Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.